Pillunat, Karin R. https://orcid.org/0000-0002-4400-6004
Kretz, Florian T. A.
Koinzer, Stefan
Müller, Philipp
Pillunat, Lutz E.
Klabe, Karsten
Funding for this research was provided by:
Carl Zeiss Meditec AG
Technische Universität Dresden
Article History
Received: 12 January 2024
Accepted: 4 December 2024
First Online: 15 December 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki and was approved by the responsible Ethics Commission at the TU Dresden (MPG ff-EK-24012020) and the involved local Ethics Commissions at the participating study sites as well as by the German Competent Authority BfArM (EUDAMED: CIV-19–12-031046). The study is registered at clinicaltrials.gov under NCT04519814. The extension was also approved by EC and BfArM.
: Written informed consent was obtained from all study participants.
: K. R. P. has received lecture fees from Allergan, Abbvie, Thea, Santen, and Novartis.F.T.A.K. has received compensation for consulting, lectures, travel costs, and grants from BVI, Carl Zeiss Meditec, Teleon, Hoya, VSY, Bausch & Lomb.S.K. has received compensation for consulting from Carl Zeiss Meditec AG.P.M. has no financial interests to disclose.L. E. P. has received lecture fees from Allergan and Santen and is on the Advisory.Board for Allergan, Santen, and Aerie, and received grant support from Novartis.K.K. has received lecture fees from Abbvie, Glaukos, iStar medical, Oertli, and Carl Zeiss Meditec, has received compensation for consulting from Carl Zeiss Meditec and is on the Advisory Board for Abbvie, iStar Medical, Oertli and Santen.None of the authors has any financial interest or any conflict of interest related to the subject matter.